Markets
GE

Emerson-GE Tie Up to Boost Biopharmaceuticals Productivity

An image of a quarterly report on a screen
Credit: Shutterstock photo

Emerson Electric Co. 's EMR global business, Emerson Process Management, disclosed an alliance with GE Healthcare Life Sciences, a business unit of General Electric Company GE to jointly leverage the manufacturing efficiency of biopharmaceuticals.

In particular, Emerson will integrate its DeltaV distributed control system with GE Healthcare's high-tech comprehensive technologies for development of biologics like monoclonal antibodies, and vaccines. While Emerson's DeltaV system aids remote control and monitoring as well as connects people, processes and production through predictive technologies, GE Healthcare's vast single-use bioprocessing technologies portfolio helps lessen set up time and enhance manufacturing flexibility.

Both firms expect the installation of first DeltaV-driven GE Healthcare, which will be a FlexFactory, to conclude by the end of the year. Notably, FlexFactory is the integrated manufacturing platform of GE Healthcare that is based on single-use technologies.

The Emerson-GE Healthcare collaboration is a strategic fit in view of the flourishing demand for such processes by biopharmaceutical manufacturers. Encouragingly, these manufacturers are in high need of advanced process automation systems for escalating efficiency and curtailing costs. Hence, the collective efforts of Emerson and GE Healthcare will contribute greatly towards easing the operations of firms operating in healthcare and biopharmaceutical industries.

As a matter of fact, Emerson Process Management has been dedicatedly focusing on improving its clients' business performances across varied industries. Last month, the firm introduced a breakthrough technology - Project Certainty - to facilitate transformational enhancement in the capital projects' implementation. The company's main motive of launching this advanced engineering-based approach is to aid its clients in attaining Top Quartile project performance via eradicating costs and trimming complexities. Such initiatives go a long way in boosting Emerson's client base and top-line growth.

Emerson currently carries a Zacks Rank #3 (Hold). Better-ranked stocks in the same industry are CUI Global, Inc. CUI and Federal Signal Corp. FSS , with a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

EMERSON ELEC CO (EMR): Free Stock Analysis Report

GENL ELECTRIC (GE): Free Stock Analysis Report

FED SIGNAL CP (FSS): Free Stock Analysis Report

CUI GLOBAL INC (CUI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GE OEG EMR FSS

Other Topics

Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More